Financials
- Market Capitalization 8.71 B
- Employee 399
- Founded 1993
- CEO Michael S Weiss
- Website www.tgtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000FVZQY1
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
20.05
売上高対価格比率
10.98
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 974 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.95 USD | 0.00% | +0.12% | +1.40% | +106.69% | 9.01 B USD | ||
| 995 | ABVX Abivax SA - American Depositary Shares | 111.08 USD | -2.28% | -4.81% | -11.14% | +33.45% | 8.72 B USD | ||
| 1016 | IBRX ImmunityBio, Inc. - Common Stock | 7.95 USD | +1.02% | -2.81% | +17.08% | +234.03% | 8.43 B USD | ||
| 1018 | APGE Apogee Therapeutics, Inc. - Common Stock | 135.07 USD | -0.01% | +0.12% | +0.61% | +152.04% | 8.40 B USD |